Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidone
- 20 September 1973
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 32 (4), 523-532
- https://doi.org/10.1016/s0002-9149(73)80044-x
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Propranolol Inhibition of Renin SecretionThe New England Journal of Medicine, 1972
- The Syndrome of Essential Hypertension and Suppressed Plasma Renin ActivityArchives of Internal Medicine, 1972
- APPARENTLY ISOLATED EXCESS DEOXYCORTICOSTERONE IN HYPERTENSION: A Variant of the Mineralocorticoid-excess SyndromeThe Lancet, 1972
- Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular diseaseThe American Journal of Medicine, 1972
- Hyporeninemic hypertensionThe American Journal of Medicine, 1972
- Essential Hypertension: Renin and Aldosterone, Heart Attack and StrokeThe New England Journal of Medicine, 1972
- Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid ExcessAnnals of Internal Medicine, 1971
- Effect of Spironolactone in Hypertensive PatientsThe American Journal of the Medical Sciences, 1970
- Effects Morbidity of Treatment on in HypertensionJAMA, 1970
- Effects of Treatment on Morbidity in HypertensionJAMA, 1967